BioLife Solutions (BLFS) Competitors $22.43 +0.35 (+1.59%) Closing price 04/15/2025 04:00 PM EasternExtended Trading$22.42 -0.02 (-0.07%) As of 04/15/2025 04:47 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock BLFS vs. SLNO, IRTC, PRCT, NVST, TMDX, LIVN, ENOV, NVCR, LMAT, and CNMDShould you be buying BioLife Solutions stock or one of its competitors? The main competitors of BioLife Solutions include Soleno Therapeutics (SLNO), iRhythm Technologies (IRTC), PROCEPT BioRobotics (PRCT), Envista (NVST), TransMedics Group (TMDX), LivaNova (LIVN), Enovis (ENOV), NovoCure (NVCR), LeMaitre Vascular (LMAT), and CONMED (CNMD). These companies are all part of the "medical equipment" industry. BioLife Solutions vs. Soleno Therapeutics iRhythm Technologies PROCEPT BioRobotics Envista TransMedics Group LivaNova Enovis NovoCure LeMaitre Vascular CONMED BioLife Solutions (NASDAQ:BLFS) and Soleno Therapeutics (NASDAQ:SLNO) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, risk, valuation, dividends, analyst recommendations, profitability, media sentiment, community ranking and earnings. Which has higher earnings and valuation, BLFS or SLNO? Soleno Therapeutics has lower revenue, but higher earnings than BioLife Solutions. BioLife Solutions is trading at a lower price-to-earnings ratio than Soleno Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBioLife Solutions$82.25M12.72-$66.43M-$0.50-44.54Soleno TherapeuticsN/AN/A-$38.99M-$4.26-16.32 Do institutionals & insiders have more ownership in BLFS or SLNO? 93.2% of BioLife Solutions shares are owned by institutional investors. Comparatively, 97.4% of Soleno Therapeutics shares are owned by institutional investors. 2.2% of BioLife Solutions shares are owned by company insiders. Comparatively, 12.3% of Soleno Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Does the media prefer BLFS or SLNO? In the previous week, Soleno Therapeutics had 2 more articles in the media than BioLife Solutions. MarketBeat recorded 13 mentions for Soleno Therapeutics and 11 mentions for BioLife Solutions. Soleno Therapeutics' average media sentiment score of 1.26 beat BioLife Solutions' score of 0.76 indicating that Soleno Therapeutics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment BioLife Solutions 6 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Soleno Therapeutics 6 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Does the MarketBeat Community prefer BLFS or SLNO? Soleno Therapeutics received 8 more outperform votes than BioLife Solutions when rated by MarketBeat users. Likewise, 72.56% of users gave Soleno Therapeutics an outperform vote while only 67.10% of users gave BioLife Solutions an outperform vote. CompanyUnderperformOutperformBioLife SolutionsOutperform Votes31267.10% Underperform Votes15332.90% Soleno TherapeuticsOutperform Votes32072.56% Underperform Votes12127.44% Is BLFS or SLNO more profitable? Soleno Therapeutics has a net margin of 0.00% compared to BioLife Solutions' net margin of -38.98%. BioLife Solutions' return on equity of -6.61% beat Soleno Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets BioLife Solutions-38.98% -6.61% -5.54% Soleno Therapeutics N/A -61.99%-55.21% Do analysts prefer BLFS or SLNO? BioLife Solutions presently has a consensus price target of $31.17, suggesting a potential upside of 39.96%. Soleno Therapeutics has a consensus price target of $99.63, suggesting a potential upside of 43.26%. Given Soleno Therapeutics' stronger consensus rating and higher possible upside, analysts plainly believe Soleno Therapeutics is more favorable than BioLife Solutions.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BioLife Solutions 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 3.00Soleno Therapeutics 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 2 Strong Buy rating(s) 3.22 Which has more volatility & risk, BLFS or SLNO? BioLife Solutions has a beta of 1.93, meaning that its share price is 93% more volatile than the S&P 500. Comparatively, Soleno Therapeutics has a beta of -2.29, meaning that its share price is 329% less volatile than the S&P 500. SummarySoleno Therapeutics beats BioLife Solutions on 13 of the 18 factors compared between the two stocks. Remove Ads Get BioLife Solutions News Delivered to You Automatically Sign up to receive the latest news and ratings for BLFS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BLFS vs. The Competition Export to ExcelMetricBioLife SolutionsElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.04B$3.10B$5.33B$7.55BDividend YieldN/A1.81%5.11%4.33%P/E Ratio-20.9514.4521.8017.80Price / Sales12.7244.60377.9393.21Price / CashN/A44.0938.1534.64Price / Book2.903.326.433.99Net Income-$66.43M$94.03M$3.20B$247.23M7 Day Performance7.89%6.28%6.37%7.11%1 Month Performance-10.93%-7.85%-8.70%-6.38%1 Year Performance42.02%-21.52%10.26%-0.29% BioLife Solutions Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BLFSBioLife Solutions2.0282 of 5 stars$22.43+1.6%$31.17+39.0%+43.0%$1.05B$82.25M-21.16440News CoverageSLNOSoleno Therapeutics4.7804 of 5 stars$69.64+3.2%$99.63+43.1%+82.4%$3.19BN/A-20.9830Analyst ForecastGap DownHigh Trading VolumeIRTCiRhythm Technologies0.9177 of 5 stars$100.17-0.2%$119.73+19.5%-8.0%$3.15B$591.84M-27.521,790Positive NewsPRCTPROCEPT BioRobotics2.3993 of 5 stars$50.83-0.8%$94.29+85.5%+4.6%$2.79B$224.50M-26.07430Positive NewsGap DownHigh Trading VolumeNVSTEnvista4.3811 of 5 stars$15.27-1.4%$20.18+32.2%-21.0%$2.63B$2.51B-2.3512,700Analyst ForecastAnalyst RevisionNews CoveragePositive NewsGap DownTMDXTransMedics Group2.7688 of 5 stars$69.15+2.2%$122.70+77.4%-5.1%$2.33B$441.54M73.56210LIVNLivaNova3.555 of 5 stars$35.40-1.5%$61.17+72.8%-34.8%$1.92B$1.25B84.292,900News CoveragePositive NewsGap DownHigh Trading VolumeENOVEnovis2.2051 of 5 stars$32.41-0.4%$58.50+80.5%-44.7%$1.85B$2.11B-14.806,800Gap DownNVCRNovoCure3.3286 of 5 stars$16.61+0.7%$35.80+115.5%+29.4%$1.83B$605.22M-11.861,320LMATLeMaitre Vascular3.2609 of 5 stars$79.39-0.5%$95.25+20.0%+31.3%$1.79B$219.86M43.38490News CoveragePositive NewsHigh Trading VolumeCNMDCONMED4.706 of 5 stars$55.34-1.6%$77.20+39.5%-35.5%$1.71B$1.31B13.054,100News CoveragePositive News Remove Ads Related Companies and Tools Related Companies Soleno Therapeutics Competitors iRhythm Technologies Competitors PROCEPT BioRobotics Competitors Envista Competitors TransMedics Group Competitors LivaNova Competitors Enovis Competitors NovoCure Competitors LeMaitre Vascular Competitors CONMED Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BLFS) was last updated on 4/16/2025 by MarketBeat.com Staff From Our PartnersGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredDOGE tax surpriseElon Musk's DOGE agents have some very strange plans for the IRS... Recently, it emerged that our tax auth...Altimetry | SponsoredAmazon ShockerJeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...Stansberry Research | SponsoredCaught on Camera: Elon Musk’s “Area 51”You won’t believe what tech legend Jeff Brown found in what he calls Elon Musk’s “Area 51.” (Click here to see...Brownstone Research | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioLife Solutions, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioLife Solutions With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BLFS Stock Free BLFS Stock Alerts